Tenascin expression in human glioma cell lines and normal tissues.
about
Peptides selected for binding to clotted plasma accumulate in tumor stroma and wounds.A pilot study: 131I-antitenascin monoclonal antibody 81c6 to deliver a 44-Gy resection cavity boost.Monoclonal antibodies for brain tumour treatment.Tumor resection cavity administered iodine-131-labeled antitenascin 81C6 radioimmunotherapy in patients with malignant glioma: neuropathology aspects.Printed peptide arrays identify prognostic TNC serumantibodies in glioblastoma patients.Convection-enhanced and local delivery of targeted cytotoxins in the treatment of malignant gliomas.Recurrent glioblastoma multiforme: advances in treatment and promising drug candidates.Glioma-specific antigens for immune tumor therapy.Antitenascin-C monoclonal antibody radioimmunotherapy for malignant glioma patients.Targeted therapies for malignant glioma: progress and potential.Tenascin-C aptamers are generated using tumor cells and purified protein.Glioma-associated antigen expression in oligodendroglial neoplasms. Tenascin and epidermal growth factor receptor.Distinct microenvironmental cues stimulate divergent TLR4-mediated signaling pathways in macrophages.Astrocytoma cell interaction with elastin substrates: implications for astrocytoma invasive potential.Substrates for astrocytoma invasion.Different susceptibility of small and large human tenascin-C isoforms to degradation by matrix metalloproteinases.Production and characterization of monoclonal antibodies specific for different epitopes of human tenascin.Tenascin in cerebrospinal fluid is a useful biomarker for the diagnosis of brain tumour.Degradation of extracellular matrix protein tenascin-C by cathepsin B: an interaction involved in the progression of gliomas.
P2860
Q30807745-0B8E0764-E02F-4A7F-AF85-EDEFA3B8E4CBQ33378699-69AC7CE2-501F-4C4E-A15D-AAB8E1E18378Q35873775-97019FC7-F9AD-4E59-9EEC-0724B01491F2Q35951631-5C297310-F136-4B79-9C52-13A8D0CFEA5BQ35955393-F71D7122-430A-4BFD-B16F-1D73B087ADC8Q36478643-71E767A1-63BB-4E68-8A5D-032E23802B1FQ36668246-C0FB42FB-9801-455D-A594-65B64678213FQ36690281-D8468A19-3EE7-449C-ABEE-043826CD1552Q36817119-D9497151-24D1-400C-97B2-0E131A3A9BF2Q37159549-E9A39018-678F-43E2-8222-9F97CB49F6A9Q38296050-7BB95719-1342-4C57-82FB-EC3373BDA357Q38464426-A4FE76E0-1D00-47B7-A1E8-147B07541141Q39438851-E8279646-94E8-4E0E-B565-A9C7E1DDB048Q40980125-1D60C23D-7525-4D22-9F28-817D1ADDEFDDQ41322756-4FFCABA2-2D40-414C-82F4-10513417B780Q41350591-B3FCE7F6-2D02-4A08-B8CD-234DFB7E7C46Q41521191-AC42C7F6-F52C-4394-A283-2FF211CF38EAQ42173852-68ED7806-1446-49B1-8E05-F8AB8DDA95DEQ44219945-0EF1A300-AF9A-435C-8048-D6B6A3685D48
P2860
Tenascin expression in human glioma cell lines and normal tissues.
description
1992 nî lūn-bûn
@nan
1992年の論文
@ja
1992年論文
@yue
1992年論文
@zh-hant
1992年論文
@zh-hk
1992年論文
@zh-mo
1992年論文
@zh-tw
1992年论文
@wuu
1992年论文
@zh
1992年论文
@zh-cn
name
Tenascin expression in human glioma cell lines and normal tissues.
@en
type
label
Tenascin expression in human glioma cell lines and normal tissues.
@en
prefLabel
Tenascin expression in human glioma cell lines and normal tissues.
@en
P2093
P1476
Tenascin expression in human glioma cell lines and normal tissues.
@en
P2093
Bourdon MA
Lightner VA
Ostrowski LE
Ventimiglia JB
Wikstrand CJ
P356
10.1016/0165-5728(92)90029-K
P577
1992-01-01T00:00:00Z